RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Effect of Thiazolidinedione Treatment on Progression of Subclinical Atherosclerosis in Premenopausal Women at High Risk for Type 2 Diabetes
Xiang, A., Peters, R., Kjos, S., Ochoa, C., Marroquin, A., Goico, J., Tan, S., Wang, C., Azen, S., Liu, C.-R., Hodis, H., & Buchanan, T. (2005). Effect of Thiazolidinedione Treatment on Progression of Subclinical Atherosclerosis in Premenopausal Women at High Risk for Type 2 Diabetes. Journal of Clinical Endocrinology and Metabolism, Vol. 90(No. 4), 1986 - 91.